These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 23320950)

  • 1. Identifying mild and severe preeclampsia in asymptomatic pregnant women by levels of cell-free fetal DNA.
    Jakobsen TR; Clausen FB; Rode L; Dziegiel MH; Tabor A
    Transfusion; 2013 Sep; 53(9):1956-64. PubMed ID: 23320950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High levels of fetal DNA are associated with increased risk of spontaneous preterm delivery.
    Jakobsen TR; Clausen FB; Rode L; Dziegiel MH; Tabor A
    Prenat Diagn; 2012 Sep; 32(9):840-5. PubMed ID: 22711432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of assisted reproductive technology on the association between first-trimester pregnancy-associated plasma protein a and human chorionic gonadotropin and adverse pregnancy outcomes.
    Zhong Y; Bradshaw R; Stanley AP; Odibo AO
    Am J Perinatol; 2011 May; 28(5):347-54. PubMed ID: 21082535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low maternal serum pregnancy-associated plasma protein-A as a risk factor of preeclampsia.
    Luewan S; Teja-Intr M; Sirichotiyakul S; Tongsong T
    Singapore Med J; 2018 Jan; 59(1):55-59. PubMed ID: 28451695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of extreme first-trimester free human chorionic gonadotropin-beta, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes.
    Krantz D; Goetzl L; Simpson JL; Thom E; Zachary J; Hallahan TW; Silver R; Pergament E; Platt LD; Filkins K; Johnson A; Mahoney M; Hogge WA; Wilson RD; Mohide P; Hershey D; Wapner R;
    Am J Obstet Gynecol; 2004 Oct; 191(4):1452-8. PubMed ID: 15507982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First-trimester maternal plasma cell-free fetal DNA and preeclampsia.
    Sifakis S; Zaravinos A; Maiz N; Spandidos DA; Nicolaides KH
    Am J Obstet Gynecol; 2009 Nov; 201(5):472.e1-7. PubMed ID: 19631923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First trimester predictors of adverse pregnancy outcomes.
    Brameld KJ; Dickinson JE; O'Leary P; Bower C; Goldblatt J; Hewitt B; Murch A; Stock R
    Aust N Z J Obstet Gynaecol; 2008 Dec; 48(6):529-35. PubMed ID: 19133038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PAPP-A levels of late pregnancy in preeclampsia and HELLP syndrome.
    Atis A; Aydin Y; Basol E; Kaleli S; Turgay F; Goker N
    Arch Gynecol Obstet; 2012 Jan; 285(1):45-9. PubMed ID: 21533533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.
    Falcon O; Auer M; Gerovassili A; Spencer K; Nicolaides KH
    Ultrasound Obstet Gynecol; 2006 Feb; 27(2):151-5. PubMed ID: 16388509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-free nucleic acids as potential markers for preeclampsia.
    Hahn S; Rusterholz C; Hösli I; Lapaire O
    Placenta; 2011 Feb; 32 Suppl():S17-20. PubMed ID: 21257079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on the relation between concentration of circulating non-host fetal DNA in pregnant women and pre-eclampsia].
    Tao H; Wang XM; Ji XH
    Zhonghua Fu Chan Ke Za Zhi; 2005 Dec; 40(12):808-11. PubMed ID: 16412324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First trimester maternal serum free β-human chorionic gonadotropin and pregnancy-associated plasma protein A in pregnancies complicated by diabetes mellitus.
    Savvidou MD; Syngelaki A; Muhaisen M; Emelyanenko E; Nicolaides KH
    BJOG; 2012 Mar; 119(4):410-6. PubMed ID: 22324916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second-trimester levels of pregnancy-associated plasma protein-A and free beta-hCG in pregnancies with trisomy 13.
    Spencer K; Crossley JA; Aitken DA; Nicolaides KH
    Prenat Diagn; 2005 May; 25(5):358-61. PubMed ID: 15906423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Low PAPP-A levels between 11 and 13(+6) weeks of gestation and the risk of preeclampsia].
    Stoykova V; Vagarova R; Markov D; Kremensky I; Ivanov S
    Akush Ginekol (Sofiia); 2010; 49(6):19-25. PubMed ID: 21427871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial).
    Dugoff L; Hobbins JC; Malone FD; Porter TF; Luthy D; Comstock CH; Hankins G; Berkowitz RL; Merkatz I; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Vidaver J; D'Alton ME
    Am J Obstet Gynecol; 2004 Oct; 191(4):1446-51. PubMed ID: 15507981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of impending fetal death.
    Spencer K; Cowans NJ; Avgidou K; Nicolaides KH
    Ultrasound Obstet Gynecol; 2006 Oct; 28(5):637-43. PubMed ID: 16952214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down syndrome biochemical markers and screening for preeclampsia at first and second trimester: correlation with the week of onset and the severity.
    Kang JH; Farina A; Park JH; Kim SH; Kim JY; Rizzo N; Elmakky A; Jun HS; Hahn WB; Cha DH
    Prenat Diagn; 2008 Aug; 28(8):704-9. PubMed ID: 18655226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of adverse pregnancy outcomes by combinations of first and second trimester biochemistry markers used in the routine prenatal screening of Down syndrome.
    Huang T; Hoffman B; Meschino W; Kingdom J; Okun N
    Prenat Diagn; 2010 May; 30(5):471-7. PubMed ID: 20440736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low levels of maternal serum PAPP-A in the first trimester and the risk of pre-eclampsia.
    Spencer K; Cowans NJ; Nicolaides KH
    Prenat Diagn; 2008 Jan; 28(1):7-10. PubMed ID: 18000943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-free fetal DNA and adverse outcome in low risk pregnancies.
    Stein W; Müller S; Gutensohn K; Emons G; Legler T
    Eur J Obstet Gynecol Reprod Biol; 2013 Jan; 166(1):10-3. PubMed ID: 23021026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.